Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives (THPBs) as proprotein convertase subtilisin/kexin type 9 (PCSK9) modulators for the treatment of hyperlipidemia
Chenglin Wu(Shanghai Institute of Materia Medica), Hong Liu(North West Agriculture and Forestry University)
Cited by 26
Related Papers
Polarity and proliferation are controlled by distinct signaling pathways downstream of PI3-kinase in breast epithelial tumor cells
|The Journal of Cell Biology|2004|218
Discovery of a 3-(4-Pyrimidinyl) Indazole (MLi-2), an Orally Available and Selective Leucine-Rich Repeat Kinase 2 (LRRK2) Inhibitor that Reduces Brain Kinase Activity
|Journal of Medicinal Chemistry|2017|147
Bioinspired large Stokes shift small molecular dyes for biomedical fluorescence imaging
|Science Advances|2022|122
Gene repression via multiplex gRNA strategy in Y. lipolytica
|Microbial Cell Factories|2018|72